A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Risdiplam (RO7034067) in Healthy Japanese Participants
Clinical trial NCT03040635 · COMPLETED
Trial details
- NCT number
- NCT03040635
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-22
- Primary completion
- 2017-10-02
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.